Header Logo

Connection

MONICA CHEN to Survival Rate

Back to Details
This is a "connection" page, showing publications MONICA CHEN has written about Survival Rate.
MONICA CHEN
Connection Strength
0.162
Survival Rate
  1. Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. J Thorac Oncol. 2026 03; 21(3):103505.
    View in: PubMed
    Score: 0.162
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.